Tubal, Zyrahlyn M.

HRN: 28-24-58  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/31/2026
CEFUROXIME 1.5GM (VIAL)
05/31/2026
06/07/2026
IV
230mg
Q8H
T/C Measles Pneumonia
Checking Initial Appropriateness 
06/03/2026
CEFUROXIME 250MG/5ML, 50ML SUSPENSION (BOT)
06/03/2026
06/07/2026
PO
2ml
BID
Measle Pneumonia
Checking Final Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: